COMMENTARY

• Gakkai, Specialty Certification and Industry by Mark Colby
  September 10, 2007

• COMENTARY：Korosho Required to Cut \220 Bil. in Social Security Spending
  September 3, 2007

• COMMENTARY／NHI Drug Pricing System Reform: Many Similarities in Proposals from JPMA, PhRMA, EFPIA
  August 27, 2007

• COMMENTARY／Range of Drugs Re-priced due to Expansion of Market May Be Expanded
  July 23, 2007

• COMMENTARY／Market for Osteoporosis Drugs Booms
  July 9, 2007

• COMMENTARY／Pressure Mounting on Long-Listed Original Drugs
  July 9, 2007

• COMMENTARY：Generic Firms Need Stronger Business Platform to Ensure Nationwide Stable Supply
  June 25, 2007

• COMMENTARY／Provisional Deliveries without Agreement on Prices
  June 11, 2007

• COMMENTARY／Show Road Map to the Goal - 30% Share for Generics
  June 4, 2007

• COMMENTARY／Korosho to Consider Introduction of CU System
  May 28, 2007

• Explosion of Shin-Etsu Chemical's Cellulose Production PlantGood Opportunity to Reconsider Raw Material Procurement System 
  April 30, 2007

• COMMENTARY／Japan Moves toward Affiliation with PIC/S
  April 23, 2007

• COMMENTARY／India Attracts Increasing Attention of Japanese Pharmas
  April 16, 2007

• COMMENTARY：Growing Market for Biopharmaceuticals
  April 2, 2007

• Japanese Pharma Companies' Licensing Policy: 1　（2） Takeda Pharmaceutical Co., Ltd.
  March 26, 2007

• Comentary
  March 26, 2007

• Japanese Pharma Companies' Licensing Policy: 1　（1） Takeda Pharmaceutical Co., Ltd.
  March 26, 2007

• Future of the Life Sciences Industries: Strategies for Success in 2015
  March 19, 2007

• 3 Advantages of Gov't-Private Sector Dialogue Industry Needs to Continuously Present Proposals
  February 19, 2007

• Breakthrough Pipelines of Japanese Pharma Companies Keiji Nakamura, Ph. D. Pharma Forum Institute, Kamakura 248-0026
  February 12, 2007

ページ